These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31447536)

  • 1. Outcomes of Inpatient Administration of Restricted Antineoplastic Medications at a Large Academic Medical Institution.
    Lau KM; Derry K; Dalton A; Martino J
    P T; 2019 Aug; 44(8):481-496. PubMed ID: 31447536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Outcomes Associated with a Pharmacist-Adjudicated Formulary Consult Service in a Veterans Affairs Medical Center.
    Britt RB; Hashem MG; Bryan WE; Kothapalli R; Brown JN
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1051-61. PubMed ID: 27579827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change.
    Ramser KL; Sprabery LR; Hamann GL; George CM; Will A
    J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.
    Park Y; Raza S; George A; Agrawal R; Ko J
    J Manag Care Spec Pharm; 2017 Aug; 23(8):893-901. PubMed ID: 28737993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aligning Formulary Restrictions Across a Health System and Improving Access to and Clarity of Medication Restrictions.
    Solano S; Dow J; Audley T; Bangalore N
    P T; 2019 Jan; 44(2):64-68. PubMed ID: 30766012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Cost Savings with Specialty Biologic Drugs Administered to Adult Inpatients with Inflammatory Bowel Disease.
    Pitman S; Jones C; Polyak S; Taylor A; Cerven-Jenn D; Reist D
    Hosp Pharm; 2022 Feb; 57(1):112-116. PubMed ID: 35521007
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a tool to allocate inpatient specialized pharmacy resources at a comprehensive cancer center.
    Smith AT; Kennerly-Shah JM; Kusoski CL
    J Oncol Pharm Pract; 2020 Oct; 26(7):1686-1694. PubMed ID: 32865162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inpatient Antineoplastic Medication Administration And Associated Drug Costs: Institution of a Hospital Policy Limiting Inpatient Administration.
    Foster AE; Reeves DJ
    P T; 2017 Jun; 42(6):388-393. PubMed ID: 28579726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of discharge medication orders following automatic therapeutic substitution of commonly exchanged drug classes.
    Glaholt S; Hayes GL; Wisniewski CS
    P T; 2014 Apr; 39(4):267-77. PubMed ID: 24757364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does circle priming improve smart infusion pump and electronic health record interoperability for chemotherapy in a pediatric hematology/oncology setting?
    Agedal KJ; Steidl KE; Burgess JL; Seabury RW; Wojnowicz SR
    J Oncol Pharm Pract; 2024 Jan; 30(1):159-164. PubMed ID: 37078113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of economic predictions to make formulary decisions.
    Picone MF; Wisniewski CS; Hayes GL
    Am J Health Syst Pharm; 2019 Feb; 76(Supplement_1):S15-S20. PubMed ID: 30753317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly developed algorithm for switching outpatient medications to medications listed in the hospital formulary: a prospective real-word evaluation in patients admitted electively to hospital.
    Möller F; Oetting M; Spiegel A; Zube O; Bertsche T
    Eur J Clin Pharmacol; 2024 Aug; 80(8):1197-1207. PubMed ID: 38656416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of an integrated pharmacy supply management strategy.
    Amerine LB; Calvert DR; Pappas AL; Lee SM; Valgus JM; Savage SW
    Am J Health Syst Pharm; 2017 Dec; 74(24):2071-2075. PubMed ID: 29222365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting.
    Corsi MP; Shea K; W Knoebel R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1324-1330. PubMed ID: 31822200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.
    Wyatt H; Zuckerman AD; Hughes ME; Arnall J; Miller R
    J Oncol Pharm Pract; 2022 Apr; 28(3):627-634. PubMed ID: 35037778
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of a high-impact medication therapy subcommittee within a large academic medical center.
    Mernick F; Akrap A; MacCormack-Gagnon J
    Am J Health Syst Pharm; 2023 Jan; 80(1):e46-e52. PubMed ID: 36087114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.